Trident Texofab Share Price History and Returns 2017 to 2024
Trident Texofab Limited | |||
 | Price: ₹158.60 | ||
| 52 Week Low: ₹36.15 52 Week High: ₹165.10 | |||
| Market Capital: 48.73 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Trident Texofab Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Trident Texofab Recent Performance
- 3: Trident Texofab Stock Price Chart From 2017 to 2024
- 4: Trident Texofab Stock Price History Table From 2017 to 2024
- 5: Analyzing the Impact of Investing in Trident Texofab
- 5.1: Trident Texofab Stock Returns In Last 5 Years
- 6: Trident Texofab Returns vs Bank FD Returns
Trident Texofab Stock Highlights
As of 26 Dec 2024, Trident Texofab Stock price is ₹158.60 which is ₹6.50 below 52-week high of ₹165.10 and ₹122.45 above 52-week low of ₹36.15
52-Week High Low
- Trident Texofab 52-Week High is ₹165.10 occurred on 23 Dec 2024
- Trident Texofab 52-Week Low is ₹36.15 occurred on 03 Jul 2024
All Time High
- The all-time high or the highest price that Trident Texofab stocks have ever touched was ₹206.00 and this occurred on 26 Dec 2024.
- The highest closing price at which Trident Texofab stocks have ever closed was ₹161.80 recorded on 26 Dec 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Trident Texofab Recent Performance
Over the past 15 trading days, the value of Trident Texofab's stock has increased by ₹28.20 (+21.63%). On 05 Dec 2024, its one share was worth ₹130.4 and by 26 Dec 2024, the value jumped to ₹158.6. During this period it created a highest high of ₹165.10 and lowest low of ₹130.35.
Click on legend items to show/hide respective price lines
Trident Texofab Stock Price Chart From 2017 to 2024
Click on legend items to show/hide respective price lines
Trident Texofab Stock Price History Table From 2017 to 2024
| Year | Trident Texofab | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2024 | ₹158.60 | 150.5% | ↑ ₹165.00 ↓ ₹36.15 |
| 2023 | ₹63.29 | -32.3% | ↑ ₹95.15 ↓ ₹52.26 |
| 2022 | ₹93.35 | 95.4% | ↑ ₹206.00 ↓ ₹46.10 |
| 2021 | ₹47.75 | 54.2% | ↑ ₹54.00 ↓ ₹22.40 |
| 2020 | ₹30.95 | -21.9% | ↑ ₹49.50 ↓ ₹24.00 |
| 2019 | ₹39.58 | -2.6% | ↑ ₹47.08 ↓ ₹31.67 |
| 2018 | ₹40.62 | 1.2% | ↑ ₹61.35 ↓ ₹33.75 |
| 2017 | ₹40.12 | - | ↑ ₹43.20 ↓ ₹17.08 |
Analyzing the Impact of Investing in Trident Texofab
Trident Texofab Stock price in the year 2017 was ₹40.12. If you had invested ₹10,000 in Trident Texofab Stock in 2017, in 7 years, your investment would have grown to ₹39,531 by the end of 2024. This represents a positive return of 295% from 2017 to 2024, with a compound annual growth rate (CAGR) of 21.6%.
Trident Texofab Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹206.00 and lowest was: ₹22.40
- Trident Texofab Stock price in 2019 was ₹39.58
- By 2024, its stock price rose to ₹158.60
- It gave a positive return of over 300.7% with a CAGR of 32.0% over the last 5 years
- If you had invested ₹10,000 in Trident Texofab in 2019 then in 5 years, your investment would have grown to ₹40,070.74 by 2024, which is 4.01 times of your initial investment.
Trident Texofab Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Trident Texofab Shares | ₹10,000 | ₹39,531.4 | 295.3% |
| Bank FD (Simple Interest) | ₹10,000 | ₹14,200 | 42.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹15,036.3 | 50.4% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
